Skip to main content

Advertisement

SpringerLink
Log in

Immune hemolysis after fludarabine-based reduced intensity conditioning and allogeneic PBSC transplantation for CML with minor ABO incompatibility

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Maris MB, Sandmaier BM, Storer BE, Chauncey T, Stuart MJ, Maziarz RT et al (2004) Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood 104:3535–3542

    Article  PubMed  CAS  Google Scholar 

  2. Myint H, Copplestone JA, Orchard J, Craig V, Curtis D, Prentice AG, Hamon MD, Oscier DG, Hamblin TJ (1995) Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 91(2):341–344

    Article  PubMed  CAS  Google Scholar 

  3. Klumpp TR (1991) Immunohematologic complications of bone marrow transplantation. Bone Marrow Transplant 8(3):159–170

    PubMed  CAS  Google Scholar 

  4. Panaro F, DeChristopher PJ, Rondelli D, Testa G, Sankary H, Popescu M, Benedetti E (2004) Severe hemolytic anemia due to passenger lymphocytes after living-related bowel transplant. Clin Transplant 18:332–335

    Article  PubMed  CAS  Google Scholar 

  5. Yazer MH, Triulzi DJ (2007) Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation. Curr Opin Hematol 14:664–670

    Article  PubMed  Google Scholar 

  6. Petz LD (2005) Immune hemolysis associated with transplantation. Semin Hematol 42:145–155

    Article  PubMed  CAS  Google Scholar 

  7. Di Raimondo F, Giustolisi R, Cacciola E, O’Brien S, Kantarjian H, Robertson LB, Keating MJ (1993) Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leuk Lymphoma 11:63–68

    Article  PubMed  Google Scholar 

  8. Gonzalez H, Leblond V, Azar N, Sutton L, Gabarre J, Binet JL, Vernant JP, Dighiero G (1998) Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. Hematol Cell Ther 40:113–118

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology and Bone Marrow Transplantation Unit, Real-Hospital Português, Recife, PE, Brazil

    Rodolfo Calixto, Fabiana Ostronoff, Mauricio Ostronoff, Alexandre Sucupira, Rodrigo Florêncio, Ana Patricia Souto Maior & Mariana Coutinho Domingues

  2. New York Blood Center, New York City, NY, USA

    Visalam Chandrasekaran

  3. 7729 Sunnyside Ave North, Seattle, WA, 98103, USA

    Fabiana Ostronoff

Authors
  1. Rodolfo Calixto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabiana Ostronoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mauricio Ostronoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alexandre Sucupira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rodrigo Florêncio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ana Patricia Souto Maior
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mariana Coutinho Domingues
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Visalam Chandrasekaran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabiana Ostronoff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calixto, R., Ostronoff, F., Ostronoff, M. et al. Immune hemolysis after fludarabine-based reduced intensity conditioning and allogeneic PBSC transplantation for CML with minor ABO incompatibility. Ann Hematol 91, 295–297 (2012). https://doi.org/10.1007/s00277-011-1245-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-011-1245-9

Keywords

Search

Navigation